Vericel Corp. - VCEL Net earnings per share for the last four quarters

Public company logo of Vericel Corp. (VCEL)

Vericel Corporation (VCEL) relies on its own biomaterial processing plants while utilizing external logistics. Unique cellular solutions ensure a steady cash flow. The YoY TTM EPS dynamics on the GURU.Markets base chart clearly demonstrate a trend where the value 147.70 captures this metric. Management's high level of expertise in implementing niche, high-margin products guarantees the precise execution of all financial plans.

VCEL: vcel.com Net earnings per share for the last 12 months 02/11/2024 - 11/17/2026

VCEL (Vericel Corporation): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental company valuation:VCEL (Vericel)
Core merchandise of Vericel Inc.

The scaling of Vericel Corporation (VCEL) within the cell therapy segment and the high margins of MACI patents drive the business's capitalization efficiency. The rolling annual growth rate of net income per share reflects the EPS growth pace over twelve months, measuring the ability to generate returns exceeding borrowing costs, while sharp spikes on the chart necessitate a review of the issuer's short-term liabilities.